These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10892758)

  • 21. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease.
    Lagerqvist B; Diderholm E; Lindahl B; Husted S; Kontny F; Ståhle E; Swahn E; Venge P; Siegbahn A; Wallentin L
    Heart; 2005 Aug; 91(8):1047-52. PubMed ID: 16020594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease.
    Sätre H; Holmvang L; Wagner GS; Lindahl B; Wallentin L
    Eur Heart J; 1999 May; 20(9):645-52. PubMed ID: 10208784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment.
    Jernberg T; Abrahamsson P; Lindahl B; Johanson P; Wallentin L; Dellborg M
    Eur Heart J; 2002 Jul; 23(14):1093-101. PubMed ID: 12090747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease.
    Diderholm E; Andrén B; Frostfeldt G; Genberg M; Jernberg T; Lagerqvist B; Lindahl B; Wallentin L
    Eur Heart J; 2002 Jan; 23(1):41-9. PubMed ID: 11741361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease.
    Diderholm E; Andrén B; Frostfeldt G; Genberg M; Jernberg T; Lagerqvist B; Lindahl B; Wallentin L
    Am J Med; 2003 Dec; 115(8):606-12. PubMed ID: 14656612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trial.
    Goyal A; Samaha FF; Boden WE; Wade MJ; Kimmel SE
    J Am Coll Cardiol; 2002 May; 39(10):1601-7. PubMed ID: 12020486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Tegn N; Abdelnoor M; Aaberge L; Endresen K; Smith P; Aakhus S; Gjertsen E; Dahl-Hofseth O; Ranhoff AH; Gullestad L; Bendz B;
    Lancet; 2016 Mar; 387(10023):1057-1065. PubMed ID: 26794722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.
    Fox KA; Poole-Wilson PA; Henderson RA; Clayton TC; Chamberlain DA; Shaw TR; Wheatley DJ; Pocock SJ;
    Lancet; 2002 Sep; 360(9335):743-51. PubMed ID: 12241831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.
    Fernandez-Avilés F; Alonso JJ; Castro-Beiras A; Vázquez N; Blanco J; Alonso-Briales J; López-Mesa J; Fernández-Vazquez F; Calvo I; Martínez-Elbal L; San Román JA; Ramos B;
    Lancet; 2004 Sep 18-24; 364(9439):1045-53. PubMed ID: 15380963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term management--the way forward?
    Wallentin L
    Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I13-7. PubMed ID: 10680039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.
    Fox KA; Poole-Wilson P; Clayton TC; Henderson RA; Shaw TR; Wheatley DJ; Knight R; Pocock SJ
    Lancet; 2005 Sep 10-16; 366(9489):914-20. PubMed ID: 16154018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute management--how should we intervene?
    Kontny F
    Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I8-12. PubMed ID: 10680038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dalteparin for acute coronary syndromes.
    O'Loughlin DC
    Heart Dis; 1999; 1(5):329-36. PubMed ID: 11720639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.
    Boden WE; O'Rourke RA; Crawford MH; Blaustein AS; Deedwania PC; Zoble RG; Wexler LF; Kleiger RE; Pepine CJ; Ferry DR; Chow BK; Lavori PW
    N Engl J Med; 1998 Jun; 338(25):1785-92. PubMed ID: 9632444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term administration of Dalteparin in unstable coronary syndrome. FRISC II study opens novel therapeutic perspectives. Fragmin and Fast Revascularization during Instability in Coronary Artery Disease].
    Arnheim K
    Internist (Berl); 2000 Jan; 41(1):A35-6. PubMed ID: 10712085
    [No Abstract]   [Full Text] [Related]  

  • 37. ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease--the FRISC II ECG substudy. Fragmin and Fast Revascularisation during Instability in Coronary artery disease.
    Mahadevan VS; Adgey AA
    Eur Heart J; 2002 Jan; 23(1):3-5. PubMed ID: 11741353
    [No Abstract]   [Full Text] [Related]  

  • 38. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.
    Damman P; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ;
    J Am Coll Cardiol; 2010 Mar; 55(9):858-64. PubMed ID: 20045278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
    Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.